JPRN-jRCTs041190018已完成2 期
A phase II trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the clinical course of anastomotic leakage after esophagectomy
Kodera Yasuhiro0 个研究点目标入组 10 人开始时间: 2019年4月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
The effect of treatment with Abound on the duration of treatment was explored in patients with esophageal cancer who developed anastomotic leakage after esophagectomy. No significant reduction in the duration of treatment was observed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Age <= 20 years
- •2) Performance status (PS) 0-2
- •3) Patients who underwent esophagectomy for esophageal cancer
- •4) Patients who were diagnosed as an anastomotic leakage within 14 days after esophagectomy
- •5) Written informed consent
排除标准
- •1) Severe pneumonia and sepsis
- •2) Leakage at the closed stump of duodenum and jejunum
- •3) Repeated surgery
- •4) Patients requiring a limiting of the water amount
- •5) Patients incompatible to Abound
- •6) Pregnancy
- •7) Ineligible for the study at the physician's assessment
研究者
相似试验
已完成
2 期
An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United StatesParkinson's DiseaseNCT00237263Novartis285
已完成
2 期
A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected ParticipantsHepatitis C, ChronicNCT02268864Janssen-Cilag International NV106
已完成
2 期
A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac AmyloidosisTTR-mediated AmyloidosisNCT02292186Alnylam Pharmaceuticals25
已完成
2 期
Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of SchizophreniaSchizophreniaNCT00580125Pfizer164
终止
2 期
SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System MalignanciesColorectal CancerNCT05039944Sichuan Baili Pharmaceutical Co., Ltd.7